S 2400 creates a workgroup to study blood clots and pulmonary embolisms in the state. The workgroup, appointed by the governor and legislative leaders, will include healthcare providers, patients, family members, and advocates. It must study annual incidence rates, current data collection methods, patient impacts, care standards, emerging treatments, and develop a risk surveillance system. The workgroup will issue policy recommendations within one year to improve patient awareness, surveillance in healthcare facilities (like hospitals), and written risk notices for patients. These recommendations will be published by the health department after submission.
Strengthens protections for patients regarding sexual misconduct by medical providers; requires medical expert consultants involved in investigations disclose conflicts of interest and to not be under investigation, on warning, or on probation; requires a zero-tolerance policy to be adopted and training to be provided on sexual misconduct by the board for professional misconduct; includes provisions related to the right to have a chaperone; includes sexual misconduct in the definition of professional misconduct.
This bill requires coroners, pathologists, medical examiners, and other qualified medical professionals to report cases of Lyme or other tick-borne diseases discovered during post-mortem examinations to the state health department. It directly affects medical examiners and public health officials by mandating timely reporting of such cases. The key provision specifies that reporting must follow methods set by the health commissioner, ensuring standardized data collection. The goal is to improve public health tracking of tick-borne disease fatalities without changing treatment or prevention policies.
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
Creates a wholesale prescription drug importation program which complies with federal standards and regulations for the purpose of generating substantial savings for consumers.
This bill (S 1796) requires health insurance plans to cover services provided by certified recovery peer advocates and specific inpatient treatment services for people with substance use disorders. It amends coverage rules to include these services when delivered through programs certified or authorized by the Office of Addiction Services and Supports. The key change ensures that peer advocacy support and inpatient care at certified facilities become part of standard insurance coverage, rather than requiring separate authorization. This directly affects individuals receiving substance use disorder treatment at approved facilities. The bill does not create new services but mandates their inclusion in existing coverage requirements.
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
Requires anti-bias training for every medical student, medical resident and physician assistant student in the state; requires the department of health to make an annual report on the implementation and effectiveness of such training.
Expands health care services provided by telehealth to include services delivered through a facility licensed under article twenty-eight of the public health law that is eligible to be designated or has received a designation as a federally qualified health center, including those facilities that are also licensed under article thirty-one or article thirty-two of the mental hygiene law.
Relates to requiring a medical facility or related service to obtain express prior written consent before filming and/or broadcasting of visual images of a patient's medical treatment.